Heart failure and oral bacteria: How could be prevented?
作者信息
Tavana Ali M
机构信息
Health Research Center, Baqiyatallah (a.s), University of Medical Sciences, Tehran, Iran.
出版信息
J Cardiovasc Dis Res. 2010 Jul;1(3):161. doi: 10.4103/0975-3583.70924.
Abstract
摘要
相似文献
1
Heart failure and oral bacteria: How could be prevented?心力衰竭与口腔细菌：如何预防？
J Cardiovasc Dis Res. 2010 Jul;1(3):161. doi: 10.4103/0975-3583.70924.
2
Oral levosimendan prevents postinfarct heart failure and cardiac remodeling in diabetic Goto-Kakizaki rats.口服左西孟旦可预防糖尿病 Goto-Kakizaki 大鼠心肌梗死后心力衰竭和心脏重构。
J Hypertens. 2009 Oct;27(10):2094-107. doi: 10.1097/HJH.0b013e32832f0ce4.
3
Oral anticoagulation versus antiplatelet or placebo for stroke prevention in patients with heart failure and sinus rhythm: Systematic review and meta-analysis of randomized controlled trials.口服抗凝剂与抗血小板或安慰剂治疗心力衰竭伴窦性心律患者的卒中预防：随机对照试验的系统评价和荟萃分析。
Int J Stroke. 2019 Dec;14(9):856-861. doi: 10.1177/1747493019877296. Epub 2019 Sep 16.
4
Inhibition of Na(+)-H(+) exchange prevents hypertrophy, fibrosis, and heart failure in beta(1)-adrenergic receptor transgenic mice.抑制钠氢交换可预防β1肾上腺素能受体转基因小鼠的心肌肥厚、纤维化和心力衰竭。
Circ Res. 2002 Apr 19;90(7):814-9. doi: 10.1161/01.res.0000014966.97486.c0.
5
Prevention of tolerance to hemodynamic effects of nitrates with concomitant use of hydralazine in patients with chronic heart failure.在慢性心力衰竭患者中联合使用肼屈嗪预防对硝酸盐血流动力学效应的耐受性。
J Am Coll Cardiol. 1995 Dec;26(7):1575-80. doi: 10.1016/0735-1097(95)00368-1.
6
Β-adrenergic blockade combined with subcutaneous B-type natriuretic peptide: a promising approach to reduce ventricular arrhythmia in heart failure?β-肾上腺素能阻断联合皮下 B 型利钠肽：减少心力衰竭室性心律失常的有前途方法？
Heart. 2014 Jun;100(11):833-41. doi: 10.1136/heartjnl-2013-305167. Epub 2014 Mar 25.
7
Anticoagulation versus placebo for heart failure in sinus rhythm.窦性心律心力衰竭的抗凝治疗与安慰剂对照
Cochrane Database Syst Rev. 2012 Jun 13(6):CD003336. doi: 10.1002/14651858.CD003336.pub2.
8
Oral Iron Therapy for Heart Failure With Reduced Ejection Fraction: Design and Rationale for Oral Iron Repletion Effects on Oxygen Uptake in Heart Failure.口服铁剂治疗射血分数降低的心力衰竭：口服铁剂补充对心力衰竭患者摄氧量影响的研究设计与原理
Circ Heart Fail. 2016 May;9(5). doi: 10.1161/CIRCHEARTFAILURE.115.000345.
9
Antiplatelet versus anticoagulation treatment for patients with heart failure in sinus rhythm.窦性心律心力衰竭患者的抗血小板治疗与抗凝治疗对比
Cochrane Database Syst Rev. 2016 Sep 15;9(9):CD003333. doi: 10.1002/14651858.CD003333.pub3.
10
The oral Ca/calmodulin-dependent kinase II inhibitor RA608 improves contractile function and prevents arrhythmias in heart failure.口服钙/钙调蛋白依赖性激酶II抑制剂RA608可改善心力衰竭时的收缩功能并预防心律失常。
ESC Heart Fail. 2020 Oct;7(5):2871-2883. doi: 10.1002/ehf2.12895. Epub 2020 Jul 20.
本文引用的文献
1
Roles of oral bacteria in cardiovascular diseases--from molecular mechanisms to clinical cases: Cell-surface structures of novel serotype k Streptococcus mutans strains and their correlation to virulence.口腔细菌在心血管疾病中的作用——从分子机制到临床病例：新型血清型 k 变异链球菌菌株的细胞表面结构及其与毒力的相关性。
J Pharmacol Sci. 2010;113(2):120-5. doi: 10.1254/jphs.09r24fm. Epub 2010 May 24.
2
[Infective endocarditis: what's new? European Society of Cardiology (ESC) Guidelines 2009 on the prevention, diagnosis and treatment of infective endocarditis].[感染性心内膜炎：有哪些新进展？欧洲心脏病学会（ESC）2009年感染性心内膜炎预防、诊断和治疗指南]
Presse Med. 2010 Jun;39(6):704-9. doi: 10.1016/j.lpm.2010.03.003.
3
[Risk factors for coronary heart disease and actual diagnostic criteria for diabetes mellitus].[冠心病的危险因素及糖尿病的实际诊断标准]
Vojnosanit Pregl. 2009 Dec;66(12):973-8. doi: 10.2298/vsp0912973m.
4
5
Isolation of P. corporis from oral cavity: what is the role of this bacterium in the mouth and other parts of the human body?从口腔中分离出人体丙酸杆菌：这种细菌在口腔及人体其他部位扮演着什么角色？
Indian J Dent Res. 2009 Jan-Mar;20(1):129. doi: 10.4103/0970-9290.49053.
6
Relationship between periodontal infections and systemic disease.牙周感染与全身性疾病之间的关系。
Clin Microbiol Infect. 2007 Oct;13 Suppl 4:3-10. doi: 10.1111/j.1469-0691.2007.01798.x.
7
Oral streptococci and cardiovascular disease: searching for the platelet aggregation-associated protein gene and mechanisms of Streptococcus sanguis-induced thrombosis.口腔链球菌与心血管疾病：寻找血链球菌诱导血栓形成的血小板聚集相关蛋白基因及机制
J Periodontol. 2005 Nov;76(11 Suppl):2101-5. doi: 10.1902/jop.2005.76.11-S.2101.
8
Phospholipid analogues of Porphyromonas gingivalis.
J Appl Microbiol. 2000 May;88(5):791-9. doi: 10.1046/j.1365-2672.2000.01026.x.
9
Role of Porphyromonas gingivalis, Prevotella intermedia, and Prevotella nigrescens in extraoral and some odontogenic infections.牙龈卟啉单胞菌、中间普氏菌和变黑普氏菌在口外及某些牙源性感染中的作用。
Clin Infect Dis. 1997 Sep;25 Suppl 2:S194-8. doi: 10.1086/516205.
10
Clinical and microbiologic findings that may contribute to dental implant failure.可能导致牙种植体失败的临床和微生物学发现。
Int J Oral Maxillofac Implants. 1990 Spring;5(1):31-8.
Zotero 插件